\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ \\ 220\\/160\ \(0\)\
\-\ somnolent\\ and\\ hard\\ to\\ arouse\ \(0\)\
\-\ not\\ oriented\\ to\\ person\\,\\ place\\,\\ time\\.\ \(0\)\
\-\ with\\ anti\\-hypertensive\\ therapy\\ the\\ pathologic\\ changes\\ on\\ follow\\-up\\ ct\\ resolved\ \(0\)\
\-\ low\\ attenuation\\ changes\\ on\\ ct\\ involving\\ the\\ occipital\\ and\\ posterior\\ parietal\\ lobes\\.\ \(0\)\
\-\ posterior\\ reversible\\ leukoencephalopathy\\,\\ pres\ \(0\)\
\-\ posterior\\ reversible\\ encephalopathy\\ syndrome\ \(0\)\
\-\ cerebral\\ infarction\ \(29\)\
\-\ encephalitis\ \(55\)\
\-\ this\\ 37\\ y\\.o\\.\\ man\\ presents\\ with\\ somnolence\\ and\\ markedly\\ elevated\\ blood\\ pressure\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ reversible\\:\\ 0\\.35141644507376435\ \(0\)\
\-\ posterior\\:\\ 0\\.23570544553547307\ \(0\)\
\-\ arouse\\:\\ 0\\.23218230777788443\ \(0\)\
\-\ somnolent\\:\\ 0\\.2185762586583724\ \(0\)\
\-\ somnolence\\:\\ 0\\.21372004952971513\ \(0\)\
\-\ pres\\:\\ 0\\.18759526178718544\ \(0\)\
\-\ changes\\:\\ 0\\.183650056375163\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.1830179600071635\ \(0\)\
\-\ person\\:\\ 0\\.17175499508311892\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.16005228465441598\ \(0\)\
\-\ encephalitis\\:\\ 0\\.15109020921060956\ \(0\)\
\-\ hard\\:\\ 0\\.15025778495026876\ \(0\)\
\-\ oriented\\:\\ 0\\.13698159030541704\ \(0\)\
\-\ place\\:\\ 0\\.13698159030541704\ \(0\)\
\-\ resolved\\:\\ 0\\.13648832790461968\ \(0\)\
\-\ markedly\\:\\ 0\\.13415038865960638\ \(0\)\
\-\ occipital\\:\\ 0\\.13001256624174187\ \(0\)\
\-\ 37\\:\\ 0\\.12944381705046265\ \(0\)\
\-\ lobes\\:\\ 0\\.1267691226913713\ \(0\)\
\-\ pathologic\\:\\ 0\\.1244939860032071\ \(0\)\
\-\ bp\\:\\ 0\\.1232761552182861\ \(0\)\
\-\ parietal\\:\\ 0\\.12268750344973843\ \(0\)\
\-\ infarction\\:\\ 0\\.11927678807908179\ \(0\)\
\-\ attenuation\\:\\ 0\\.11625365926558046\ \(0\)\
\-\ ct\\:\\ 0\\.11568849266930929\ \(0\)\
\-\ pressure\\:\\ 0\\.11568813041143708\ \(0\)\
\-\ involving\\:\\ 0\\.10642400890187012\ \(0\)\
\-\ cerebral\\:\\ 0\\.10526408360385205\ \(0\)\
\-\ elevated\\:\\ 0\\.10357819941341376\ \(0\)\
\-\ and\\:\\ 0\\.09418842039681094\ \(0\)\
\-\ on\\:\\ 0\\.09177580478672484\ \(0\)\
\-\ syndrome\\:\\ 0\\.0915975681509525\ \(0\)\
\-\ time\\:\\ 0\\.09005752026576093\ \(0\)\
\-\ blood\\:\\ 0\\.08823982604880053\ \(0\)\
\-\ therapy\\:\\ 0\\.08729827027821703\ \(0\)\
\-\ low\\:\\ 0\\.08718288204684649\ \(0\)\
\-\ man\\:\\ 0\\.08043789596788846\ \(0\)\
\-\ to\\:\\ 0\\.07596843358984282\ \(0\)\
\-\ presents\\:\\ 0\\.07309005006450424\ \(0\)\
\-\ the\\:\\ 0\\.06063429718492277\ \(0\)\
\-\ not\\:\\ 0\\.05998153225053181\ \(0\)\
\-\ with\\:\\ 0\\.05950274369593075\ \(0\)\
\-\ this\\:\\ 0\\.052208653935806475\ \(0\)\
